Schwarz N, Genelin F, Schwarz AF
FDA staff stated the compound lacks sufficient information to know whether the drug would cause harm when administered to humans. The committees public docket drew approximately 1,860 comments before the July 23-24 hearing, reflecting broad interest from patients, clinicians, and compounding pharmacists
Animal toxicology studies spanning three decades have found no evidence of mutagenic, genotoxic, or carcinogenic effects
There is no clinical evidence from human studies that BPC-157 at therapeutic doses causes kidney damage
Initial Consultation Comprehensive review of your health history, symptoms, and wellness goals Duration: 30 minutes 1 Diagnostic Bloodwork Thorough laboratory analysis of hormonal levels and relevant health markers before starting treatment